Compare PLNT & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLNT | GRFS |
|---|---|---|
| Founded | 1992 | 1940 |
| Country | United States | Spain |
| Employees | N/A | 25247 |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.9B |
| IPO Year | 2015 | N/A |
| Metric | PLNT | GRFS |
|---|---|---|
| Price | $53.21 | $7.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 2 |
| Target Price | ★ $107.46 | $10.15 |
| AVG Volume (30 Days) | ★ 1.6M | 701.4K |
| Earning Date | 05-07-2026 | 07-28-2022 |
| Dividend Yield | N/A | ★ 1.80% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $1,324,144,000.00 | N/A |
| Revenue This Year | $19.22 | $4.49 |
| Revenue Next Year | $11.66 | $6.42 |
| P/E Ratio | $38.47 | ★ $18.67 |
| Revenue Growth | ★ 12.06 | N/A |
| 52 Week Low | $37.03 | $6.96 |
| 52 Week High | $114.26 | $11.14 |
| Indicator | PLNT | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 53.30 | 55.58 |
| Support Level | $49.50 | $7.38 |
| Resistance Level | $54.47 | $7.73 |
| Average True Range (ATR) | 1.57 | 0.16 |
| MACD | 0.37 | 0.08 |
| Stochastic Oscillator | 58.77 | 65.96 |
Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.